Here’s why Walgreens and CVS retail pharmacies are struggling — and what they’re doing to fix it
Drugstores remain an important fixture of the U.S. health-care system that tens of millions of Americans rely on, but they
Read More
Biotechnology
What’s next for the Biden administration’s Medicare drug price negotiations
The Medicare negotiations are a multi-round process that could produce more savings for taxpayers and seniors and put more pressure
Read More
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
It is a milestone in a controversial process that aims to make costly medications more affordable for older Americans but
Read More
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Ro said it hopes its new tool will be able to help patients understand their GLP-1 coverage options so they
Read More
Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance
Read More
Patients on Alzheimer’s drug Leqembi see benefits over three years, Eisai study says
The study results on Leqembi, which Eisai shares with Biogen, also found that Alzheimer's patients who take the therapy get
Read More
Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda
The drugmaker raised its full-year sales forecast to $63.4 billion to $64.4 billion on increased demand for key products, particularly
Read More
European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai
The committee said Leqembi's effect on delaying cognitive decline does not outweigh "the risk of serious side effects associated with
Read More
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
The results come as Bristol Myers moves to cut $1.5 billion in costs by 2025 and reinvest that money into
Read More